It is plausible that alterations beyond KIT and PDGFRA mutations may contribute to CNS metastasis, as some studies have suggested that mutations in genes involved in epithelial-mesenchymal transition and the PI3K/AKT/mTOR signaling pathway could enhance tumor invasiveness and facilitate BBB penetration [8]. This evidence concerns the gene MTOR and neoplasm.